Ask Endeavour Vision’s Katie Ellias what song best represents her career path to venture capital and she’d probably say, “The Long and Winding Road.” Hear how the VC established a career path that took her from Pre-Med plans to Medtronic and then Venture Capital.

Jonathan Norris of Silicon Valley Bank follows up his recent Medtech Conference presentation with insights on healthcare exits, the latest M&A chatter, the resurgence of biopharma deals, which type of Medtech start-up gets the most action, and the drastic decline in Series A device deals.

SightLine general partner Joe Biller shares his insights on the venture market, including advice for companies looking for – and working with – venture capital investors.

What steps did Boston Scientific – under Mahoney’s leadership – take to unlock such significant growth? In an interview at the Medtech Conference, Mahoney – interviewed by Kevin Hykes, CEO of Metavention - laid out some of the meaningful changes Boston Scientific made.

Serial entrepreneur Mike Berman shares how he’s seen the Medtech innovation sector evolve over the years. Times are tougher, but Berman sees reason for hope as well as concern.

This week, New Enterprise Associates – known to its friends as NEA – announced closing on a $3.3 billion venture capital fund, with roughly 10% of that total going to Medtech companies. We asked partner Justin Klein, MD, how might the $300 million or so invest in Medtech companies be deployed differently than in the prior fund.

Andrew Weiss, president & CEO of ReCor Medical, says Medtech is alive and kicking. This is an exceedingly positive statement from the CEO of a renal denervation company, an area that has been particularly hit hard. Hear his take on Medtech’s future and how Recor is making it work.

Duke Rohlen, CEO and director of Ajax Health, co-founder and CEO of Spirox Inc., explains how he’s combining his expertise, connections, and experience exiting Medtech companies with KKR’s capital to devise a new way to run start-ups.

Joe Almeida, CEO, President, and Chairman of Baxter International, Inc. joined Baxter at the beginning of 2016. He knew immediately the company needed an infusion of innovative spirit to begin to move forward.

Medtech Conference Co-Chair Kevin Hykes, who is finishing up his two-year tour of duty as a conference co-commander, reviews the agenda for next week’s Conference.